3Dバイオプリンティング市場：コンポーネント（3Dバイオプリンター（マイクロ押出、インクジェット、レーザー、磁気）、バイオインク（天然、合成、ハイブリッド））、材料（ハイドロゲル、生細胞）、アプリケーション（研究、臨床）、エンドユーザー（バイオファーマ、アカデミア）-2027年までの世界市場予測

3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material(Hydrogel, Living Cells), Application (Research, Clinical), End user (Biopharma, Academia) - Global Forecast to 2027

3Dバイオプリンティングの世界市場は、2022年に13億米ドルと推定され、予測期間中にCAGR20.8%で2027年には33億米ドルに達すると予測されています。3Dバイオプリンターや生体材料の技術的進歩、製薬や美容業界にお... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年7月12日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	259	335	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

3Dバイオプリンティングの世界市場は、2022年に13億米ドルと推定され、予測期間中にCAGR20.8%で2027年には33億米ドルに達すると予測されています。3Dバイオプリンターや生体材料の技術的進歩、製薬や美容業界における3Dバイオプリンティングの利用拡大、バイオプリンティング研究活動を支援する公的・民間資金の増加などの要因が、市場成長を後押ししています。しかし、熟練した専門家の不足、高い開発・生産コストなどの要因が、この市場の成長を抑制しています。

"予測期間中、3Dバイオプリンティング市場のコンポーネント別成長率は、3Dバイオプリンターセグメントが最も高かった"
2021年、3Dバイオプリンター部門が最も高い成長率を占めた。生物科学や生物工学の分野では、3Dバイオプリンターは生きた細胞を層ごとに印刷するのに役立つ。個人の体組織のサンプルから成長した肝臓、歯、心臓、耳、肺などの臓器全体を印刷するというアイデアは、現在進行中で世界中で非常に注目されているため、この市場の成長に有利に働いています。

「アジア太平洋地域。3Dバイオプリンティング市場において最も成長率の高い地域".
アジア太平洋地域は、予測期間中に最も高いCAGRを記録すると推定されています。この市場の高い成長率は、theincreasing research activities, growing demand for organ transplants, increasing number of initiatives by market players for expanding their presence in the APAC, and the higher adoption of stem cell research in several Asian countriesに起因するものであると考えられる。

本レポートのために実施した主なインタビューは以下のように分類されます。

- 回答者別供給側80％、需要側20
- 職位別Cレベル（マネージャー）45％、Dレベル（CXO、ディレクター）30％、その他（エグゼクティブ）25％。
- 地域別地域別：北米20％、欧州10％、アジア太平洋55％、中南米10％、中東・アフリカ5
報告書に掲載された企業一覧
- BICO Group AB（米国）
- オルガノボ・ホールディングス・インク（米国）
- Allevi, Inc. (3D Systems, Inc.の一部) (米国)
- CollPlant Biotechnologies Ltd.(イスラエル)
- regenHU（スイス）
- EnvisionTEC GmbH (Desktop Metalの一部) (ドイツ)
- アスペクト・バイオシステムズ社（カナダ(カナダ)
- アドバンスト・ソリューションズ・ライフサイエンス社（米国）
- サイフーズ・バイオメディカル株式会社（日本）
- ROKIT Healthcare, Inc.(韓国)
- レジェノボ・バイオテクノロジー Co.(シャイニング3Dテック社傘下) (中国)
- パンドラム・テクノロジーズ・プライベート・リミテッド（インド(インド)
- フォルディンク・ライフサイエンス・テクノロジーズ（アルメニア）
- Revotek Co.(米国)
- プレサイスバイオ（米国）
- ブリンター社（フィンランド）
- プレリスバイオロジクス（米国）
- レジェマット3D（スペイン）
- 3Dバイオセラピューティック社（米国）
- Tissue Regeneration Systems Inc.
- ポイエティス（フランス）
- SunP Biotech, LLC（米国）
- Vivax Bio, LLC（米国）
- GeSiM mbH（ドイツ）
- Manchester BIOGEL(イギリス)。
調査対象範囲
本レポートは、世界の3Dバイオプリンティング市場の詳細図を提供します。それはそのようなthecomponent、材料、アプリケーション、エンドユーザーや地域などの異なるセグメント間で市場の規模と将来の成長の可能性を推定することを目的としています。また、彼らの会社概要、最近の動向や主要な市場戦略と一緒に主要な市場プレイヤーのoftheの詳細な競争力のある分析が含まれています。

レポートを購入する主な利点。
本レポートは、3Dバイオプリンティング市場全体とそのサブセグメントに関する収益数の最も近い概算を提供することにより、市場リーダー/新規参入者を支援します。また、利害関係者が競争環境をより良く理解し、より良いビジネスの位置付けと適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。本レポートは、ステークホルダーが市場の脈動を理解し、主要な市場ドライバー、課題、阻害要因、トレンド、機会に関する情報を提供することを可能にします。

ページTOPに戻る

1 INTRODUCTION 37
1.1 OBJECTIVES OF THE STUDY 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY 38
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 YEARS CONSIDERED FOR THE STUDY 39
1.4 CURRENCY 39
1.5 LIMITATIONS 39
1.6 STAKEHOLDERS 40
1.7 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
FIGURE 1 RESEARCH DESIGN 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Key data from secondary sources 43
2.1.2 PRIMARY DATA 44
FIGURE 2 BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET 44
2.2 MARKET ESTIMATION METHODOLOGY 45
FIGURE 3 3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021 45
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021 46
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 47
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 47
2.3 MARKET GROWTH RATE PROJECTIONS 48
FIGURE 6 3D BIOPRINTING MARKET (SUPPLY SIDE): CAGR PROJECTIONS 48
FIGURE 7 3D BIOPRINTING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF
DEMAND-SIDE FACTORS 49
2.4 DATA TRIANGULATION 49
FIGURE 8 DATA TRIANGULATION METHODOLOGY 50
2.5 RESEARCH ASSUMPTIONS 50
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS 51
2.6 RISK ANALYSIS 51
3 EXECUTIVE SUMMARY 52
FIGURE 9 3D BIOPRINTING MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 10 3D BIOPRINTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 53
FIGURE 11 3D BIOPRINTING MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION) 54
FIGURE 12 3D BIOPRINTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 54
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET 55
4 PREMIUM INSIGHTS 56
4.1 3D BIOPRINTING MARKET OVERVIEW 56
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS IN 3D BIOPRINTING INDUSTRY
TO DRIVE MARKET 56
4.2 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT AND COUNTRY (2021) 57
FIGURE 15 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN 3D BIOPRINTING MARKET IN 2021 57
4.3 3D BIOPRINTING MARKET SHARE, BY MATERIAL, 2022 VS. 2027 57
FIGURE 16 LIVING CELLS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027 57
4.4 3D BIOPRINTING MARKET SHARE, BY END USER, 2022 58
FIGURE 17 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE LARGEST
END USERS OF 3D BIOPRINTING MARKET 58
4.5 3D BIOPRINTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH FROM
2022 TO 2027 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 19 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 59
5.2.1 DRIVERS 60
5.2.1.1 Increasing use of 3D bioprinting in pharmaceutical and cosmetology industries 60
5.2.1.2 Developments in 3D bioprinting for tissue and organ regeneration applications 60
5.2.1.3 Rising public and private funding to support bioprinting research activities 61
5.2.1.4 Technological advancements in 3D bioprinting industry 61
5.2.2 RESTRAINTS 62
5.2.2.1 Dearth of skilled professionals 62
5.2.2.2 High development and production costs 62
5.2.2.3 Lack of regulatory guidelines governing 3D bioprinting 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 Rising demand for organ transplant 63
5.2.3.2 Growing awareness of 3D bioprinting 63
5.2.3.3 Growing demand for regenerative medicine and stem cell research 64
5.2.4 CHALLENGES 64
5.2.4.1 Socioethical concerns related to use of 3D-bioprinted products 64
5.2.4.2 High cost of 3D bioprinting 65
5.2.4.3 Process control and understanding of 3D bioprinters 65

5.3 RANGES/SCENARIOS 66
FIGURE 20 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES
ON GROWTH OF 3D BIOPRINTING MARKET 66
5.4 IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET 67
FIGURE 21 3D BIOPRINTING MARKET SCENARIO PRE- AND POST-COVID-19,
2020–2022 67
FIGURE 22 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68
5.5 PRICING ANALYSIS 68
5.6 TECHNOLOGY ANALYSIS 69
TABLE 1 COMPARISON OF BIOPRINTING TECHNIQUES 69
TABLE 2 ADVANTAGES AND DISADVANTAGES OF 3D BIOPRINTING TECHNIQUES 69
5.7 PATENT ANALYSIS 70
FIGURE 23 PATENT APPLICATIONS FOR 3D BIOPRINTING MARKET,
JANUARY 2011–MAY 2022 70
TABLE 3 INDICATIVE LIST OF PATENTS IN 3D BIOPRINTING MARKET 70
5.8 VALUE CHAIN ANALYSIS 71
FIGURE 24 VALUE CHAIN ANALYSIS OF 3D BIOPRINTING MARKET: RAW MATERIAL
AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE 72
5.8.1 RESEARCH & DEVELOPMENT (R&D) 72
5.8.2 MANUFACTURING & ASSEMBLY 72
5.8.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 72
5.9 SUPPLY CHAIN ANALYSIS 72
5.9.1 PROMINENT COMPANIES 72
5.9.2 SMALL AND MEDIUM-SIZED ENTERPRISES (SMES) 73
5.9.3 END USERS 73
FIGURE 25 3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS 73
5.10 ECOSYSTEM ANALYSIS OF 3D BIOPRINTING MARKET 74
TABLE 4 SUPPLY CHAIN ECOSYSTEM 74
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023 75
TABLE 5 3D BIOPRINTING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 75
5.12 REGULATORY ANALYSIS 76
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.13 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 10 3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS 79
5.13.1 THREAT OF NEW ENTRANTS 79
5.13.2 THREAT OF SUBSTITUTES 79
5.13.3 BARGAINING POWER OF SUPPLIERS 79
5.13.4 BARGAINING POWER OF BUYERS 79
5.13.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 79
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 80
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF
3D BIOPRINTING PRODUCTS 80
5.14.2 BUYING CRITERIA FOR 3D BIOPRINTING PRODUCTS 80
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 80
6 3D BIOPRINTING MARKET, BY COMPONENT 81
6.1 INTRODUCTION 82
TABLE 11 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 82
6.2 3D BIOPRINTERS 82
6.2.1 3D BIOPRINTERS MARKET, BY TECHNOLOGY 82
TABLE 12 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 83
TABLE 13 3D BIOPRINTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 83
TABLE 14 NORTH AMERICA: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 83
TABLE 15 EUROPE: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 84
TABLE 16 ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 84
6.2.1.1 Microextrusion bioprinting 84
6.2.1.1.1 Increasing research in microextrusion fueling adoption
of this technology 84
TABLE 17 MICROEXTRUSION 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION) 85
TABLE 18 NORTH AMERICA: MICROEXTRUSION 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 86
TABLE 19 EUROPE: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 86
TABLE 20 ASIA PACIFIC: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.2.1.2 Inkjet 3D bioprinting 87
6.2.1.2.1 High cell viability and low cost resulted in increased demand for inkjet 3D bioprinting 87
TABLE 21 INKJET 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION) 88
TABLE 22 NORTH AMERICA: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 88
TABLE 23 EUROPE: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 88
TABLE 24 ASIA PACIFIC: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 89
6.2.1.3 Laser-assisted bioprinting 89
6.2.1.3.1 Laser-assisted bioprinting among highest-resolution bioprinting technologies available in 3D bioprinting industry 89
TABLE 25 LASER-ASSISTED 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION) 90
TABLE 26 NORTH AMERICA: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 27 EUROPE: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 91
TABLE 28 ASIA PACIFIC: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91
6.2.1.4 Stereolithography-based bioprinting 92
6.2.1.4.1 Stereolithography offers high printing quality, speed,
and cell viability 92
TABLE 29 STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION) 92
TABLE 30 NORTH AMERICA: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 31 EUROPE: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 93
TABLE 32 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 93
6.2.1.5 Magnetic 3D bioprinting 94
6.2.1.5.1 Accuracy and speed are major advantages of magnetic
3D bioprinting 94
TABLE 33 MAGNETIC 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION) 94
TABLE 34 NORTH AMERICA: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 35 EUROPE: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 95
TABLE 36 ASIA PACIFIC: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 96
6.2.1.6 Other technologies 96
TABLE 37 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2020–2027 (USD MILLION) 96
TABLE 38 NORTH AMERICA: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 39 EUROPE: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 40 ASIA PACIFIC: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION) 98
6.3 BIOINKS 98
TABLE 41 BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 42 BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
TABLE 43 NORTH AMERICA: BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 99
TABLE 44 EUROPE: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 45 ASIA PACIFIC: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
6.3.1 NATURAL BIOINKS 100
6.3.1.1 Natural bioinks most preferred bioink in 3D bioprinting process 100
TABLE 46 NATURAL BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION) 101
TABLE 47 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 101
TABLE 48 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 101
TABLE 49 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 102
6.3.2 HYBRID BIOINKS 102
6.3.2.1 Hybrid bioinks possess high mechanical strength and biocompatibility 102
TABLE 50 HYBRID BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION) 102
TABLE 51 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 103
TABLE 52 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 103
TABLE 53 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 103
6.3.3 SYNTHETIC BIOINKS 104
6.3.3.1 Improved mechanical strength and consistency offered
by synthetic bioinks to drive market 104
TABLE 54 SYNTHETIC BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 55 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 104
TABLE 56 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
TABLE 57 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
7 3D BIOPRINTING MARKET, BY MATERIAL 106
7.1 INTRODUCTION 107
TABLE 58 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 107
7.2 LIVING CELLS 107
7.2.1 ETHICAL ISSUES ASSOCIATED WITH USE OF LIVING CELLS IN ORGAN DEVELOPMENT TO HAMPER MARKET GROWTH 107
TABLE 59 3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION,
2020–2027 (USD MILLION) 108
TABLE 60 NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS,
BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 61 EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY,
2020–2027 (USD MILLION) 109
TABLE 62 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 109

7.3 HYDROGELS 110
7.3.1 DYNAMIC PROPERTIES OF HYDROGELS SUPPORT THEIR ADOPTION
IN 3D TISSUE ENGINEERING 110
TABLE 63 3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION,
2020–2027 (USD MILLION) 110
TABLE 64 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 65 EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY,
2020–2027 (USD MILLION) 111
TABLE 66 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION) 112
7.4 EXTRACELLULAR MATRICES 112
7.4.1 ECM HAS EMERGED AS PROMISING TOOL IN TISSUE ENGINEERING 112
TABLE 67 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2020–2027 (USD MILLION) 113
TABLE 68 NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 69 EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES,
BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 70 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES,
BY COUNTRY, 2020–2027 (USD MILLION) 114
7.5 OTHER BIOMATERIALS 115
TABLE 71 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS, BY REGION,
2020–2027 (USD MILLION) 115
TABLE 72 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 73 EUROPE: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 74 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION) 117
8 3D BIOPRINTING MARKET, BY APPLICATION 118
8.1 INTRODUCTION 119
TABLE 75 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
8.2 RESEARCH APPLICATIONS 119
TABLE 76 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2020–2027 (USD MILLION) 119
TABLE 77 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 120
TABLE 78 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 79 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 80 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 121
8.2.1 DRUG RESEARCH 122
8.2.1.1 Drug research is largest and fastest-growing segment of
3D bioprinting market 122
TABLE 81 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY REGION, 2020–2027 (USD MILLION) 122
TABLE 82 NORTH AMERICA: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 83 EUROPE: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 84 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 124
8.2.2 REGENERATIVE MEDICINE 124
8.2.2.1 Growing demand for organ transplant to support market growth 124
TABLE 85 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2020–2027 (USD MILLION) 125
TABLE 86 NORTH AMERICA: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 87 EUROPE: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 88 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION) 126
8.2.3 3D CELL CULTURE 127
8.2.3.1 Rising focus on developing alternatives to animal testing to drive market for 3D cell culture 127
TABLE 89 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY REGION, 2020–2027 (USD MILLION) 127
TABLE 90 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 91 EUROPE: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 92 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION) 129
8.3 CLINICAL APPLICATIONS 129
TABLE 93 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 94 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 130
TABLE 95 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 130
TABLE 96 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 97 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 131
8.3.1 SKIN 132
8.3.1.1 Growing number of aesthetic and reconstruction surgeries to propel market growth 132
TABLE 98 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 132
TABLE 99 NORTH AMERICA: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 100 EUROPE: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 101 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 134
8.3.2 BONE AND CARTILAGE 134
8.3.2.1 Increasing incidence of musculoskeletal conditions to drive demand for bone grafts 134
TABLE 102 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 135
TABLE 103 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 135
TABLE 104 EUROPE: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 105 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 136
8.3.3 BLOOD VESSELS 137
8.3.3.1 Increasing research activities focused on 3D bioprinting of blood vessels major factor driving market 137
TABLE 106 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 137
TABLE 107 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 137
TABLE 108 EUROPE: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 109 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 138
8.3.4 OTHER CLINICAL APPLICATIONS 139
TABLE 110 LIST OF ONGOING CLINICAL TRIALS 139
TABLE 111 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 140
TABLE 112 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 140
TABLE 113 EUROPE: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 114 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 141
9 3D BIOPRINTING MARKET, BY END USER 142
9.1 INTRODUCTION 143
TABLE 115 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 143
9.2 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES 143
9.2.1 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE FASTEST-GROWING END USERS OF 3D BIOPRINTING MARKET 143
TABLE 116 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 144
TABLE 117 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 144
TABLE 118 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 119 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 145
9.3 BIOPHARMACEUTICAL COMPANIES 146
9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE ADOPTION OF 3D BIOPRINTING 146
TABLE 120 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION) 146
TABLE 121 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 122 EUROPE: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 123 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 148
9.4 HOSPITALS 148
9.4.1 3D PRINTING OFFERS A CUSTOMIZED SURGICAL PLANNING TOOL FOR HOSPITALS 148
TABLE 124 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 149
TABLE 125 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 126 EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 127 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 150
10 3D BIOPRINTING MARKET, BY REGION 151
10.1 INTRODUCTION 152
TABLE 128 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION) 152
10.2 NORTH AMERICA 152
FIGURE 28 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT 153
TABLE 129 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 130 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 154
TABLE 131 NORTH AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 154
TABLE 132 NORTH AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 133 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 155
TABLE 134 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 135 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 137 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 156

10.2.1 US 156
10.2.1.1 US dominates global 3D bioprinting market 156
TABLE 138 US: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 157
TABLE 139 US: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 157
TABLE 140 US: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 141 US: 3D BIOINKS MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 158
TABLE 142 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 145 US: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 159
10.2.2 CANADA 160
10.2.2.1 Government initiatives to support growth of 3D bioprinting market in Canada 160
TABLE 146 CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 160
TABLE 147 CANADA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 161
TABLE 148 CANADA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 161
TABLE 150 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 153 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 163
10.3 EUROPE 163
TABLE 154 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 163
TABLE 155 EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 164
TABLE 156 EUROPE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 164
TABLE 157 EUROPE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 158 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 165
TABLE 159 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 160 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 161 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 162 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 166
10.3.1 GERMANY 166
10.3.1.1 Increasing demand for organ transplant to drive market 166
TABLE 163 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 167
TABLE 164 GERMANY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 167
TABLE 165 GERMANY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 166 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 168
TABLE 167 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 168 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 169 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 170 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 169
10.3.2 UK 170
10.3.2.1 Increased funding and grants to support research activities related to 3D bioprinting in UK 170
TABLE 171 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 170
TABLE 172 UK: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 171
TABLE 173 UK: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 174 UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 171
TABLE 175 UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 176 UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 177 UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 178 UK: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 173
10.3.3 FRANCE 173
10.3.3.1 Rising adoption of 3D bioprinting technology to propel market growth 173
TABLE 179 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 174
TABLE 180 FRANCE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 174
TABLE 181 FRANCE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 182 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 175
TABLE 183 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 184 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 185 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 186 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 176
10.3.4 ITALY 176
10.3.4.1 Italy is leading life science research hub in Europe 176
TABLE 187 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 177
TABLE 188 ITALY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 178
TABLE 189 ITALY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 190 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 178
TABLE 191 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 179
TABLE 192 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 193 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 194 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 180
10.3.5 SPAIN 180
10.3.5.1 Increasing funding from private and public organizations to aid market growth in Spain 180
TABLE 195 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 181
TABLE 196 SPAIN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 181
TABLE 197 SPAIN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 198 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 182
TABLE 199 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182
TABLE 200 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 201 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 202 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 183
10.3.6 REST OF EUROPE 183
TABLE 203 ROE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 184
TABLE 204 ROE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 184
TABLE 205 ROE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 206 ROE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 185
TABLE 207 ROE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 185
TABLE 208 ROE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 209 ROE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 210 ROE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 186

ページTOPに戻る

Table of Contents

Summary

The global 3D Bioprinting market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 3.3 billion by 2027, at a CAGR of 20.8% during the forecast period. Factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities drive the market growth. However,factors likedearth of skilled professionals and high development and production costs are restraining the growth of this market.

“The 3D Bioprinterssegmentaccounted for the highest growth rate in the 3D Bioprintingmarket, bycomponent, during the forecast period”
In 2021, the 3D Bioprinters segment accounted for the highest growth rate. In biological sciences and the bioengineering field, 3D bioprinters help in printing living cells layer-by-layer. The idea of printing entire organs—such as the liver, teeth, heart, ears, and lungs—grown from samples of an individual’s body tissue is in process and gaining tremendous attention worldwide and thus, favoring growth of this market.

“Asia Pacific: The fastest-growing regionin the3D Bioprintingmarket”
The Asia Pacific market is estimated to record the highest CAGR during the forecast period. The high growth rate of this market can beattributed to theincreasing research activities, growing demand for organ transplants, increasing number of initiatives by market players for expanding their presence in the APAC, and the higher adoption of stem cell research in several Asian countries.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80%and Demand Side 20%
• By Designation: C-level (Managers) - 45%, D-level(CXOs, Directors)- 30%, and Others (Executives) - 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• BICO Group AB (US)
• Organovo Holdings Inc. (US)
• Allevi, Inc. (part of 3D Systems, Inc.) (US)
• CollPlant Biotechnologies Ltd. (Israel)
• regenHU (Switzerland)
• EnvisionTEC GmbH (part of Desktop Metal) (Germany)
• Aspect Biosystems Ltd. (Canada)
• Advanced Solutions Life Sciences, LLC (US)
• Cyfuse Biomedical K.K. (Japan)
• ROKIT Healthcare, Inc. (South Korea)
• Regenovo Biotechnology Co., Ltd. (part of Shining 3D Tech Co., Ltd.) (China)
• Pandorum Technologies Pvt. Ltd. (India)
• Foldink Life Science Technologies (Armenia)
• Revotek Co., Ltd. (US)
• Precise Bio (US)
• Brinter (Finland)
• Prellis Biologics (US)
• Regemat 3D (Spain)
• 3DBio Therapeutics (US)
• Tissue Regeneration Systems Inc. (US)
• Poietis (France)
• SunP Biotech, LLC (US)
• Vivax Bio, LLC (US)
• GeSiM mbH (Germany)
• Manchester BIOGEL (UK).
Research Coverage:
This report provides a detailed picture of theglobal 3D Bioprinting Market. It aims at estimating the size and future growth potential of the market across different segments such as thecomponent, material, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D BioprintingMarketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, challenges, restraints,trends,and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?